Multidrug resistance-associated protein expression in clinical gastric carcinoma

Cancer
K EndoK Sugimachi

Abstract

We examined the relationship between the expression of a multi-drug resistance-associated protein (MRP) and the biologic factors regarding invasion and metastasis of human gastric cancer. In 75 patients with gastric cancer, the expression of MRP was immunohistochemically investigated and the expression of MRP mRNA was also detected using reverse transcription PCR (RT-PCR). Sensitivity to the anticancer agents, cisplatin (CDDP), doxorubicin (DXR), etoposide (VP-16), and mitomycin C (MMC) was examined using the MTT {3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl[2H]-tetra-zolium bromide} assay. The relation between MRP expression and development, invasion, and metastasis of cancer was analyzed, and overexpression of the tumor suppressor gene p53 was investigated, immunohistochemically. Immunohistochemically detected MRP positive tumors were noted in 34 of 75 excised tumors (45%), and confirmed by RT-PCR. There was no significant relation between MRP expression and clinicopathologic features or prognosis. Positive p53 staining was evident in 16 of 34 MRP positive tumors (47%) and 18 of 41 negative ones (44%), and there was no significant correlation between MRP and abnormal p53 expression. The MTT assay showed that MRP positive gastric...Continue Reading

References

Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·A SaitoK Sugimachi
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K E NoonanI B Roninson
Jan 1, 1990·Seminars in Surgical Oncology·Y MaeharaK Sugimachi
Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
May 1, 1988·The Journal of Clinical Investigation·J M CroopD E Housman
May 28, 1987·The New England Journal of Medicine·I Pastan, M Gottesman
Jul 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J O'Connell
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·M MüllerP L Jansen
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanH J Broxterman

❮ Previous
Next ❯

Citations

May 26, 1998·Journal of Clinical Gastroenterology·F J LacuevaR Carvajal
Dec 3, 1999·Biochimica Et Biophysica Acta·D R HipfnerS P Cole

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.